Market Research Industry Reports

Synergy Pharmaceuticals Inc (SGYP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Synergy Pharmaceuticals Inc (Synergy Pharma) is a biopharmaceutical company that develops and commercializes new treatments for gastrointestinal (GI) diseases. The company pioneered its R&D efforts to develop its proprietary uroguanylin-based GI platform. It is also developing analogs of uroguanylin, a naturally occurring human GI peptide that promotes normal bowel function. The companys portfolio includes Trulance (plecanatide), which is structurally identical to uroguanylin, for the treatment of chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C) in adults. Synergy Pharmas pipeline includes dolcanatide (SP-333), an investigational candidate under evaluation for the treatment of OIC and UC. Synergy Pharma is headquartered in New York, the US.

Synergy Pharmaceuticals Inc (SGYP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.




Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Synergy Pharma Acquires FV-100 From Bristol-Myers Squibb 11
Partnerships 13
Bind Therapeutics and Synergy Pharma Enter into Research Agreement 13
Licensing Agreements 14
Cipher Pharma Enters into Licensing Agreement with Synergy Pharma 14
Synergy Pharma Enters Into Agreement With Ironwood Pharma For Plecanatide 15
Equity Offering 16
Synergy Pharma Prices Public Offering of Shares for USD56 Million 16
Synergy Pharma Raises USD125 Million in Public Offering of Shares 18
Synergy Pharma Plans to Raise Funds in Public Offering of Shares 19
Synergy Pharma Raises USD89.8 Million in Private Placement of Shares 20
Synergy Pharma Announces Public Offering Of Shares For Up To US$50 Million 21
ContraVir Pharma Spin Off from Synergy Pharma 22
Synergy Pharma Completes Public Offering Of Shares For US$90 Million 23
Synergy Pharma Completes Exercise Of Underwriters Option For Public Offering Of Shares For US$51.75 Million 25
Debt Offering 27
Synergy Pharma Raises USD79.8 Million in Private Placement of Notes Due 2019 27
Synergy Pharma Raises USD200 Million in Private Placement of 7.5% Notes Due 2019 28
Acquisition 30
Synergy Pharma Completes Acquisition Of Callisto Pharma 30
Synergy Pharmaceuticals Inc - Key Competitors 31
Synergy Pharmaceuticals Inc - Key Employees 32
Synergy Pharmaceuticals Inc - Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 34
Financial Announcements 34
Mar 01, 2018: Synergy Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Business Update 34
Nov 09, 2017: Synergy Pharmaceuticals Reports Third Quarter 2017 Financial Results 36
Aug 09, 2017: Synergy Pharmaceuticals Reports Second Quarter 2017 Financial Results and Business Update 37
May 10, 2017: Synergy Pharmaceuticals Reports First Quarter 2017 Financial Results and Business Update 39
Mar 01, 2017: Synergy Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results and Business Update 41
Corporate Communications 43
Apr 17, 2017: Synergy Pharmaceuticals Appoints Gary G. Gemignani as Chief Financial Officer 43
Other Significant Developments 44
Oct 17, 2017: Synergy Pharmaceuticals Presents Results from Study Examining Patient and Physician Perceptions and Experiences with Irritable Bowel Syndrome with Constipation (IBS-C) 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List Of Tables

List of Tables
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Synergy Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Synergy Pharma Acquires FV-100 From Bristol-Myers Squibb 11
Bind Therapeutics and Synergy Pharma Enter into Research Agreement 13
Cipher Pharma Enters into Licensing Agreement with Synergy Pharma 14
Synergy Pharma Enters Into Agreement With Ironwood Pharma For Plecanatide 15
Synergy Pharma Prices Public Offering of Shares for USD56 Million 16
Synergy Pharma Raises USD125 Million in Public Offering of Shares 18
Synergy Pharma Plans to Raise Funds in Public Offering of Shares 19
Synergy Pharma Raises USD89.8 Million in Private Placement of Shares 20
Synergy Pharma Announces Public Offering Of Shares For Up To US$50 Million 21
ContraVir Pharma Spin Off from Synergy Pharma 22
Synergy Pharma Completes Public Offering Of Shares For US$90 Million 23
Synergy Pharma Completes Exercise Of Underwriters Option For Public Offering Of Shares For US$51.75 Million 25
Synergy Pharma Raises USD79.8 Million in Private Placement of Notes Due 2019 27
Synergy Pharma Raises USD200 Million in Private Placement of 7.5% Notes Due 2019 28
Synergy Pharma Completes Acquisition Of Callisto Pharma 30
Synergy Pharmaceuticals Inc, Key Competitors 31
Synergy Pharmaceuticals Inc, Key Employees 32
Synergy Pharmaceuticals Inc, Subsidiaries 33

List Of Figures

List of Figures
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Synergy Pharmaceuticals Inc (SGYP) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Synergy Pharmaceuticals Inc (Synergy Pharma) is a biopharmaceutical company that develops and commercializes new treatments for gastrointestinal (GI) diseases. The company pioneered its R&D efforts to develop its proprietary uroguanylin-based

USD 250View Report

Tiger Synergy Berhad Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Tiger Synergy Berhad Company Profile is a detailed strategic and analytical report on Tiger Synergy Berhad. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200View Report

Urigen Pharmaceuticals Inc - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Urigen Pharmaceuticals Inc (Urigen) is a specialty pharmaceutical company that develops and commercializes therapeutic products for urological disorders. The company focuses on developing innovative products for amelioration of urethritis, painful

USD 250View Report

Regeneron Pharmaceuticals Inc (REGN) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Regeneron Pharmaceuticals Inc (Regeneron) is a biopharmaceutical company, which discovers, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. The companys six US FDA-approved medicines and product

USD 250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Apr 2018
No. of Pages :45
Country :United States of America
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube